These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18416303)

  • 1. [Anti-tNFalpha therapy in chronic severe asthma].
    Tomasiak MM; Zietkowski Z; Tomasiak M; Skiepko R; Bodzenta-Lukaszyk A
    Pol Arch Med Wewn; 2006 Oct; 116(4):998-1004. PubMed ID: 18416303
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha: a promising therapeutic target for asthma?
    Heffler E; Berry M; Pavord ID
    BioDrugs; 2007; 21(6):345-9. PubMed ID: 18020618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept for refractory asthma therapy.
    Antoniu SA
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1279-81. PubMed ID: 16989602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab and other new drug therapies occupy a small space in asthma disease management.
    Curtiss FR
    J Manag Care Pharm; 2009 Apr; 15(3):289-93. PubMed ID: 19326961
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting tumour necrosis factor-alpha in corticosteroid-dependent asthma.
    Antoniu SA
    Expert Opin Ther Targets; 2006 Jun; 10(3):471-3. PubMed ID: 16706686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha in asthma.
    Berry M; Brightling C; Pavord I; Wardlaw A
    Curr Opin Pharmacol; 2007 Jun; 7(3):279-82. PubMed ID: 17475560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.
    Morjaria JB; Chauhan AJ; Babu KS; Polosa R; Davies DE; Holgate ST
    Thorax; 2008 Jul; 63(7):584-91. PubMed ID: 18245148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TNF-alpha: a novel therapeutic approach for asthma.
    Brightling C; Berry M; Amrani Y
    J Allergy Clin Immunol; 2008 Jan; 121(1):5-10; quiz 11-2. PubMed ID: 18036647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the medicine chest.
    Szpir M
    Environ Health Perspect; 2006 Feb; 114(2):A96. PubMed ID: 16482665
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.
    Holgate ST; Noonan M; Chanez P; Busse W; Dupont L; Pavord I; Hakulinen A; Paolozzi L; Wajdula J; Zang C; Nelson H; Raible D
    Eur Respir J; 2011 Jun; 37(6):1352-9. PubMed ID: 21109557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
    Tonnel AB; Denis G; Lelong J
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
    De Simone C; Carbone A; Caldarola G
    Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha in refractory asthma.
    Oliveri C; Polosa R
    N Engl J Med; 2006 May; 354(19):2074-5; author reply 2074-5. PubMed ID: 16687725
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 15. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water.
    Matera MG; Calzetta L; Cazzola M
    Pulm Pharmacol Ther; 2010 Apr; 23(2):121-8. PubMed ID: 19853667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of a role of tumor necrosis factor alpha in refractory asthma.
    Berry MA; Hargadon B; Shelley M; Parker D; Shaw DE; Green RH; Bradding P; Brightling CE; Wardlaw AJ; Pavord ID
    N Engl J Med; 2006 Feb; 354(7):697-708. PubMed ID: 16481637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor necrosis factor alpha for refractory asthma.
    Erzurum SC
    N Engl J Med; 2006 Feb; 354(7):754-8. PubMed ID: 16481645
    [No Abstract]   [Full Text] [Related]  

  • 19. Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.
    Onishi S; Yoshio T; Nagashima T; Minota S
    Mod Rheumatol; 2010 Oct; 20(5):528-30. PubMed ID: 20458607
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.